Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M519Revenue $M122Net Margin (%)16.3Z-Score5.1
Enterprise Value $M472EPS $0.3Operating Margin %19.9F-Score7
P/E(ttm))66.7Cash Flow Per Share $0Pre-tax Margin (%)16.3Higher ROA y-yY
Price/Book7.010-y EBITDA Growth Rate %0Quick Ratio3.5Cash flow > EarningsN
Price/Sales4.95-y EBITDA Growth Rate %0Current Ratio4.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)17.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)42.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M44.1ROI % (ttm)-96.2Gross Margin Increase y-yY

Gurus Latest Trades with SUPN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SUPNRobert Bruce 2014-12-31 Add0.68%$7.49 - $9.49
($8.4)
$ 11.7829%Add 73.65%694,581
SUPNRobert Bruce 2014-09-30 Add0.73%$7.99 - $11.13
($8.98)
$ 11.7824%Add 300.00%400,000
SUPNRobert Bruce 2014-06-30 Buy 0.25%$7.32 - $10.85
($8.88)
$ 11.7825%New holding100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SUPN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SUPN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bryan Jones W.VP of Business Development 2015-03-24Sell1,900$12-1.58view
Bhatt Padmanabh P.Sr. VP of IP; CSO 2013-08-19Sell2,285$8.2143.85view
BIGHAM MICHAELDirector 2013-03-22Buy35,000$5.41118.3view
SIEBERT JOHN MDirector 2013-03-21Buy3,000$5.5114.73view
Khattar Jack A.President, CEO 2013-03-15Buy10,000$6.1592.03view
PATRICK GREGORY SVP, CFO 2013-03-14Buy5,000$6.9569.93view
ORBIMED ADVISORS LLC10% Owner 2013-02-13Sell302,183$7.5556.42view
ORBIMED ADVISORS LLC10% Owner 2012-12-18Sell297,815$6.9270.66view
SIEBERT JOHN MDirector 2012-12-04Buy7,000$8.1445.09view
Abingworth Management LTD10% Owner 2012-05-04Buy1,100,000$5136.2view

Press Releases about SUPN :

    Quarterly/Annual Reports about SUPN:

    News about SUPN:

    Articles On GuruFocus.com
    Robert Bruce new Buys Feb 16 2015 
    Third Quarter Was Robert Bruce's Busiest in 2014 Nov 21 2014 
    Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 

    More From Other Websites
    SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 27 2015
    SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 24 2015
    Georges Gemayel, Ph.D., Joins Supernus Board of Directors Mar 23 2015
    Georges Gemayel, Ph.D., Joins Supernus Board of Directors Mar 23 2015
    SUPERNUS PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Mar 12 2015
    Supernus Gains on Solid Q4 Earnings, Encouraging Guidance - Analyst Blog Mar 12 2015
    Supernus Pharmaceuticals, Inc. (SUPN) Rises: Stock Up 10.8% - Tale of the Tape Mar 12 2015
    Supernus Pharmaceuticals (SUPN) Stock Is Up Today on Earnings Beat Mar 11 2015
    Supernus beats Street 4Q forecasts Mar 10 2015
    Supernus beats Street 4Q forecasts Mar 10 2015
    Supernus Announces Fourth Quarter and Full Year 2014 Results Mar 10 2015
    Supernus Announces Fourth Quarter and Full Year 2014 Results Mar 10 2015
    Supernus to Present at March Cowen Conference Feb 18 2015
    Supernus to Present at March Cowen Conference Feb 18 2015
    Supernus to Host Fourth Quarter and Full Year 2014 Earnings Conference Call Feb 17 2015
    Supernus to Host Fourth Quarter and Full Year 2014 Earnings Conference Call Feb 17 2015
    Supernus Files Oxtellar XR Patent Infringement Lawsuit Again - Analyst Blog Jan 26 2015
    SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 23 2015
    Supernus Sues TWi for Infringement of Oxtellar XR(R) Patents Jan 21 2015
    Supernus Sues TWi for Infringement of Oxtellar XR(R) Patents Jan 21 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK